These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 12437552)
1. Acitretin for erythrokeratodermia variabilis in a 9-year-old girl. Graham-Brown RA; Chave TA Pediatr Dermatol; 2002; 19(6):510-2. PubMed ID: 12437552 [TBL] [Abstract][Full Text] [Related]
2. Erythrokeratodermia variabilis with adult onset: report of a sporadic case unresponsive to systemic retinoids. Erbagci Z; Tuncel AA; Deniz H J Dermatolog Treat; 2006; 17(3):187-9. PubMed ID: 16854764 [TBL] [Abstract][Full Text] [Related]
3. [Erythrokeratodermia variabilis]. Bilan P; Levy A; Sin C; Marchal A; Sigal ML; Mahé E Ann Dermatol Venereol; 2013 Feb; 140(2):129-33. PubMed ID: 23395496 [TBL] [Abstract][Full Text] [Related]
4. Two cases of linear epidermolytic hyperkeratosis: therapeutic challenge with acitretin. Kocaturk E; Zemheri E; Kavala M; Aktas S; Sarigul S; Sudogan S Eur J Dermatol; 2010; 20(3):404-5. PubMed ID: 20388608 [No Abstract] [Full Text] [Related]
5. Both low-dose arotinoid ethylester and acitretin are effective in the treatment of familial erythrokeratodermia variabilis. Zhang L; Hong Y; Zheng S; Huo W; Qi R; Geng L; Chen HD; Gao XH Dermatol Ther; 2014; 27(4):240-3. PubMed ID: 24754264 [TBL] [Abstract][Full Text] [Related]
6. Epidermolytic hyperkeratosis: a follow-up of 23 years of use of systemic retinoids. Nassif PW; Nakandakari S; Fogagnolo L; Contin LA; Alves CJ An Bras Dermatol; 2011; 86(4 Suppl 1):S72-5. PubMed ID: 22068776 [TBL] [Abstract][Full Text] [Related]
7. [Erythrokeratodermia variabilis (EKV)--a disorder due to altered epidermal expression of gap junction proteins]. Ständer S; Stadelmann A; Traub O; Traupe H; Metze D J Dtsch Dermatol Ges; 2005 May; 3(5):354-8. PubMed ID: 16372802 [TBL] [Abstract][Full Text] [Related]
8. Erythrokeratodermia variabilis: successful treatment with retinoid plus psoralen and ultraviolet A therapy. Yüksek J; Sezer E; Köseoğlu D; Markoç F; Yildiz H J Dermatol; 2011 Jul; 38(7):725-7. PubMed ID: 21352304 [No Abstract] [Full Text] [Related]
9. Acitretin + EHK = PG: Toe web pyogenic granuloma in a man with total body epidermolytic hyperkeratosis on acitretin--report of a unique occurrence. Amin A; Shwayder T Dermatol Nurs; 2009; 21(6):345-7. PubMed ID: 20102018 [No Abstract] [Full Text] [Related]
10. Long-term safety and efficacy of continuous acitretin monotherapy for three children with different severe hyperkeratotic disorders in China. Liang J; Chen P; Chen H; Tian X; Wu Z; Zhang S; Li C; Zhang X J Dermatol; 2018 Aug; 45(8):1003-1008. PubMed ID: 29756235 [TBL] [Abstract][Full Text] [Related]
11. An appraisal of acitretin therapy in children with inherited disorders of keratinization. Lacour M; Mehta-Nikhar B; Atherton DJ; Harper JI Br J Dermatol; 1996 Jun; 134(6):1023-9. PubMed ID: 8763418 [TBL] [Abstract][Full Text] [Related]
12. Progressive symmetrical erythrokeratodermia -- case report. Guaraldi Bde M; Jaime TJ; Guaraldi Rde M; Melo DF; Nogueira OM; Rodrigues N An Bras Dermatol; 2013; 88(1):109-12. PubMed ID: 23539014 [TBL] [Abstract][Full Text] [Related]
14. [A girl with desquamation of hands and feet]. Chung PK; Vergunst CE; van der Kuip M Ned Tijdschr Geneeskd; 2014; 158():A7327. PubMed ID: 24893811 [TBL] [Abstract][Full Text] [Related]
15. Monilethrix: improvement with acitretin. Karincaoglu Y; Coskun BK; Seyhan ME; Bayram N Am J Clin Dermatol; 2005; 6(6):407-10. PubMed ID: 16343029 [TBL] [Abstract][Full Text] [Related]